AI Assistant
Blog
Pricing
Log In
Sign Up
Head and neck squamous cell carcinoma demonstrate heterogeneity in response to pembrolizumab and cetuximab ex vivo
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
